Chiara Bonetto

Turin, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Intensive Care management of Hemophagocytic Lymphohistiocytosis: a case series.

Intensive Care management of Hemophagocytic Lymphohistiocytosis: a case series.

Journal: BMC anesthesiology
Published: July 03, 2025

Hemophagocytic Lymphohistiocytosis in the adult critically ill: a narrative review of case reports and case series.

Hemophagocytic Lymphohistiocytosis in the adult critically ill: a narrative review of case reports and case series.

Journal: Frontiers in medicine
Published: May 20, 2025

Impact of Multidrug-Resistant Bacteria in a Cohort of COVID-19 Critically Ill Patients: Data from a Prospective Observational Study Conducted in a High-Antimicrobial-Resistance-Prevalence Center.

Impact of Multidrug-Resistant Bacteria in a Cohort of COVID-19 Critically Ill Patients: Data from a Prospective Observational Study Conducted in a High-Antimicrobial-Resistance-Prevalence Center.

Journal: Journal of clinical medicine
Published: November 20, 2024

Outcomes and Impact of Pre-ECMO Clinical Course in Severe COVID-19-Related ARDS Treated with VV-ECMO: Data from an Italian Referral ECMO Center.

Outcomes and Impact of Pre-ECMO Clinical Course in Severe COVID-19-Related ARDS Treated with VV-ECMO: Data from an Italian Referral ECMO Center.

Journal: Journal of clinical medicine
Published: April 21, 2024

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.

Journal: Frontiers in medicine
Published: December 12, 2022

Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation.

Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation.

Journal: Membranes
Published: June 19, 2021

ECMO Support and Operator Safety in the Context of COVID-19 Outbreak: A Regional Center Experience.

ECMO Support and Operator Safety in the Context of COVID-19 Outbreak: A Regional Center Experience.

Journal: Membranes
Published: April 05, 2021

Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia.

Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia.

Journal: British journal of clinical pharmacology
Published: February 17, 2021

V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis.

V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis.

Journal: New microbes and new infections
Published: December 31, 2018

Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome.

Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome.

Journal: BMC anesthesiology
Published: December 29, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026